Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Organizations
Organizations
Intrexon
Products 1 to 10 of 22
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Arctic Apple
by
Okanagan Specialty Fruits
+
Intrexon
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 15:47 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
XON
(NYSE)
Value chain stage:
Finished Product
Engineered Tilapia
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:57 (6 years ago)
Date last modified:
2019/09/12 14:59 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Florian™ “On Demand” Flowering
by
Intrexon
Biotech components:
Gene Editing
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:47 (6 years ago)
Date last modified:
2019/09/12 14:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
+
Novelty
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Plant
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Friendly Mosquitoes (not Aedes)
by
Intrexon
Biotech components:
Animal
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (5 years ago)
Date last modified:
2020/02/10 09:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
INXN-3004: AML
by
Intrexon
Biotech components:
Virus
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (5 years ago)
Date last modified:
2020/02/10 09:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: 1,4 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: 2,3 BDO
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
+
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane bioconversion: Farnesene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane Bioconversion: Isobutanol
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/16 16:29 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: Isobutyraldehyde
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (6 years ago)
Date last modified:
2019/09/13 11:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
1
2
3
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
